论文部分内容阅读
目的探讨蔗糖铁注射液在血液透析患者肾性贫血中的应用价值。方法选择30例维持血液透析治疗患者为研究对象,均表现出肾性贫血症状,对其行蔗糖铁注射液治疗,观察其临床疗效、不良反应、治疗前后相关指标变化情况。结果 30例患者治疗总有效率100%,不良反应发生率10%。治疗前后血清铁蛋白(SF)、血红蛋白(Hb)、转铁蛋白饱和度(TSAT)比较差异有统计学意义(P<0.01)。结论蔗糖铁注射液能有效为机体补充铁元素,改善肾性贫血症状,不良反应较少,可作为血液透析患者肾性贫血治疗的有效手段。
Objective To investigate the value of iron sucrose injection in renal anemia in hemodialysis patients. Methods Thirty patients who underwent maintenance hemodialysis were enrolled in this study. Renal anemia was observed. The patients were treated with sucrose and iron injection. The clinical efficacy, adverse reactions and the changes of related indexes before and after treatment were observed. Results The total effective rate of the 30 patients was 100%, the incidence of adverse reactions was 10%. Serum ferritin (SF), hemoglobin (Hb) and transferrin saturation (TSAT) had statistical significance before and after treatment (P <0.01). Conclusion Sucrose iron injection can effectively supplement the body with iron, improve the symptoms of renal anemia, with fewer adverse reactions, which can be used as an effective treatment for renal anemia in hemodialysis patients.